UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN C000000457
Receipt number R000000551
Scientific Title A prospective non-randomised phase II study to assess the safety and efficacy of melphalan combined with fludarabine as a reduced conditioning regimen for unrelated bone marrow transplantation for hematological malignancies (C-SHOT 0505)
Date of disclosure of the study information 2006/07/31
Last modified on 2017/02/06 09:18:47

No. Disposal Last modified on Item of update
1 Insert 2006/07/31 12:39:15
2 Update 2007/02/03 00:28:08
3 Update 2007/02/03 00:29:17 URL releasing protocol
4 Update 2011/02/03 02:16:14 UMIN ID1
5 Update 2011/02/07 10:57:09 Key inclusion criteria
Key inclusion criteria
Target sample size
6 Update 2011/02/07 11:04:45 Organization
Organization
Division name
Division name
Address
Address
Last name of contact person
Last name of contact person
Address
Email
7 Update 2011/02/07 11:09:11 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
8 Update 2012/07/31 21:29:56 Post marketing survey by drug manufacture etc., specified by Japanese law.
9 Update 2013/02/15 15:06:09 Recruitment status
10 Update 2017/02/06 09:18:47 Email
Name of primary person or sponsor
Organization